Skip to main content
Jason Comander, MD, Ophthalmology, Boston, MA, Massachusetts General Hospital

JasonComanderMDPhD

Ophthalmology Boston, MA

Retinal Disease

Massachusetts Eye & Ear Infirmary

Dr. Comander is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Comander's full profile

Already have an account?

Education & Training

  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 2010 - 2012
  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2007 - 2010
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
  • Harvard Medical School
    Harvard Medical SchoolClass of 2006

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2010 - 2024
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Enhanced Career Development Award Foundation Fighting Blindness
  • K12 Mentored Clinical Scientist Development Program Award NIH / National Eye Institute, 2012
  • Career Development Award Research for Prevention of Blindness

Publications & Presentations

PubMed

Journal Articles

  • Moving Towards PDE6A Gene Supplementation Therapy  
    Jason Comander, MD, JAMA Ophthalmology
  • Moving Towards PDE6A Gene Supplementation Therapy  
    Jason Comander, MD, JAMA Ophthalmology

Press Mentions

  • Clinical Challenges: Treating Leber Congenital Amaurosis
    Clinical Challenges: Treating Leber Congenital AmaurosisNovember 29th, 2021
  • CRISPR Used Inside a Person’s Body for the First Time Ever
    CRISPR Used Inside a Person’s Body for the First Time EverMarch 6th, 2020
  • CLINICAL TRIAL DOWNLOAD: Phase 1/2a Data on Human Retinal Progenitor Cell Therapy
    CLINICAL TRIAL DOWNLOAD: Phase 1/2a Data on Human Retinal Progenitor Cell TherapyMarch 1st, 2020
  • Join now to see all

Hospital Affiliations